Last 57.00 TWD
Change Today -0.08 / -0.14%
Volume 32.0K
4169 On Other Exchanges
Symbol
Exchange
Taiwan
As of 1:51 AM 07/25/14 All times are local (Market data is delayed by at least 15 minutes).

tcm biotech international co (4169) Snapshot

Open
56.81
Previous Close
57.08
Day High
57.50
Day Low
56.80
52 Week High
08/6/13 - 68.42
52 Week Low
12/31/13 - 39.70
Market Cap
2.6B
Average Volume 10 Days
49.5K
EPS TTM
--
Shares Outstanding
46.3M
EX-Date
--
P/E TM
--
Dividend
0.03
Dividend Yield
0.63%
Current Stock Chart for TCM BIOTECH INTERNATIONAL CO (4169)

Related News

No related news articles were found.

tcm biotech international co (4169) Related Businessweek News

No Related Businessweek News Found

tcm biotech international co (4169) Details

TCM Biotech International Corp., a biotech company, engages in the research and development of botanic drugs, health food, and functional ingredients. The company offers pharmaceutical products, including osteoarthritis treatment products, urinary system treatment products, expectorant/mucolytic agents, antineoplastic agents, iron preparations, hypertensive agents, anti-diabetic preparations, antibiotics, AMDL-ELISA DR-70 diagnostic kits for cancer, and cast and bandage protectors. It also manufactures functional ingredients comprising medicinal fungal mycelia, such as cordyceps sinensis, antrodia camphorata, etc.; and extracts active constituents from natural herbs, including rhodiola, piptoporus betulinus, etc. In addition, the company offers dietary supplements and functional drinks primarily to clinics, drugstores, and organic stores; health food products, including PHC capsules for liver function protection; ODM/OEM services to biotechnology companies, food enterprises, and sale channel merchants; and organic food products, including Voelkel natural juice, Naturata sunflower oil, and Byodo linseed oil. Further, its botanical drugs under development comprise TCM-700C for the treatment of genotype 1 hepatitis C infection; TCM 606F for nonalcoholic fatty liver therapy; TCM 808FB for liver fibrosis therapy; and TCM 800B for the treatment of hepatitis B. Additionally, the company develops health foods for anti-nonalcoholic fatty liver, anti-lever fibrosis, and anti-fatigue. TCM Biotech International Corp. sells its products in Taiwan, the United States, Japan, Singapore, Malaysia, Vietnam, the Philippines, China, and internationally. The company was founded in 1998 and is based in Taipei, Taiwan.

Founded in 1998

tcm biotech international co (4169) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4169:TT 57.00 TWD -0.08

4169 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 4169.
View Industry Companies
 

Industry Analysis

4169

Industry Average

Valuation 4169 Industry Range
Price/Earnings 100.0x
Price/Sales 8.3x
Price/Book 5.2x
Price/Cash Flow 163.8x
TEV/Sales 7.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TCM BIOTECH INTERNATIONAL CO, please visit www.tcmbio.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.